DK1499623T3 - Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on - Google Patents
Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-onInfo
- Publication number
- DK1499623T3 DK1499623T3 DK03719968T DK03719968T DK1499623T3 DK 1499623 T3 DK1499623 T3 DK 1499623T3 DK 03719968 T DK03719968 T DK 03719968T DK 03719968 T DK03719968 T DK 03719968T DK 1499623 T3 DK1499623 T3 DK 1499623T3
- Authority
- DK
- Denmark
- Prior art keywords
- methyl
- carbazol
- imidazol
- tetrahydro
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D521/00—Heterocyclic compounds containing unspecified hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37632302P | 2002-04-29 | 2002-04-29 | |
PCT/US2003/013221 WO2003093281A1 (en) | 2002-04-29 | 2003-04-29 | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1499623T3 true DK1499623T3 (da) | 2007-10-08 |
Family
ID=29401332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03719968T DK1499623T3 (da) | 2002-04-29 | 2003-04-29 | Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on |
Country Status (19)
Country | Link |
---|---|
US (2) | US7098345B2 (de) |
EP (1) | EP1499623B1 (de) |
JP (1) | JP2005529142A (de) |
KR (1) | KR20040104654A (de) |
CN (1) | CN1665823A (de) |
AT (1) | ATE364611T1 (de) |
AU (1) | AU2003223764A1 (de) |
CA (1) | CA2483566A1 (de) |
DE (1) | DE60314400T2 (de) |
DK (1) | DK1499623T3 (de) |
ES (1) | ES2288606T3 (de) |
HR (1) | HRP20041070A2 (de) |
IL (1) | IL164904A0 (de) |
MX (1) | MXPA04010846A (de) |
NO (1) | NO20045192L (de) |
PL (1) | PL373191A1 (de) |
PT (1) | PT1499623E (de) |
WO (1) | WO2003093281A1 (de) |
ZA (1) | ZA200408934B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU32003A (sh) * | 2000-10-30 | 2006-05-25 | Teva Pharmaceutical Industries Ltd. | Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje |
CA2483532A1 (en) * | 2002-04-30 | 2003-11-13 | Biogal Gyogyszergyar Rt. | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
US7696356B2 (en) * | 2004-08-17 | 2010-04-13 | Taro Pharmaceutical Industries Limited | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
US7547791B2 (en) * | 2004-10-26 | 2009-06-16 | Ipca Laboratories Ltd. | One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2561244B1 (fr) | 1984-01-25 | 1988-03-04 | Glaxo Group Ltd | Composes heterocycliques du type tetrahydrocarbazolone, procede pour leur preparation et composition pharmaceutique les comprenant |
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
EP0405617A3 (en) | 1985-03-14 | 1992-11-25 | Beecham Group P.L.C. | Medicaments for the treatment of anxiety |
GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
GB8518741D0 (en) | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Process |
GB8518745D0 (en) | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
GB8518742D0 (en) | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Process |
US4859662A (en) | 1986-11-28 | 1989-08-22 | Glaxo Group Limited | Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances |
GB8630071D0 (en) | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
GB8914804D0 (en) | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
US5344658A (en) | 1989-06-28 | 1994-09-06 | Glaxo Group Limited | Process and composition using ondansetron |
CA2112487C (en) | 1991-06-26 | 2003-04-15 | James W. Young | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
CA2106642C (en) | 1992-10-14 | 2005-08-16 | Peter Bod | Carbazolone derivatives and process for preparing the same |
GB9423511D0 (en) | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
GB9423588D0 (en) | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
CN1045437C (zh) | 1994-12-29 | 1999-10-06 | 中国科学院上海有机化学研究所 | 恩丹西酮及其生理盐的合成 |
YU32003A (sh) | 2000-10-30 | 2006-05-25 | Teva Pharmaceutical Industries Ltd. | Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje |
EP1207160A1 (de) | 2000-11-20 | 2002-05-22 | Hanmi Pharm. Co., Ltd. | Verfahren zur Herstellung von 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
CA2433720A1 (en) | 2001-01-11 | 2002-07-18 | Teva Pharmaceutical Industries Ltd. | An improved process for preparing pure ondansetron hydrochloride dihydrate |
AU2002251329A1 (en) | 2002-04-25 | 2003-11-10 | Generics (Uk) Limited | Novel crystalline forms of celecoxib and other compounds |
CA2483532A1 (en) | 2002-04-30 | 2003-11-13 | Biogal Gyogyszergyar Rt. | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
-
2003
- 2003-04-29 PL PL03373191A patent/PL373191A1/xx not_active Application Discontinuation
- 2003-04-29 US US10/425,450 patent/US7098345B2/en not_active Expired - Fee Related
- 2003-04-29 ES ES03719968T patent/ES2288606T3/es not_active Expired - Lifetime
- 2003-04-29 PT PT03719968T patent/PT1499623E/pt unknown
- 2003-04-29 JP JP2004501420A patent/JP2005529142A/ja active Pending
- 2003-04-29 DE DE60314400T patent/DE60314400T2/de not_active Expired - Fee Related
- 2003-04-29 EP EP03719968A patent/EP1499623B1/de not_active Expired - Lifetime
- 2003-04-29 DK DK03719968T patent/DK1499623T3/da active
- 2003-04-29 MX MXPA04010846A patent/MXPA04010846A/es unknown
- 2003-04-29 AT AT03719968T patent/ATE364611T1/de not_active IP Right Cessation
- 2003-04-29 AU AU2003223764A patent/AU2003223764A1/en not_active Abandoned
- 2003-04-29 KR KR10-2004-7017346A patent/KR20040104654A/ko not_active Application Discontinuation
- 2003-04-29 CA CA002483566A patent/CA2483566A1/en not_active Abandoned
- 2003-04-29 WO PCT/US2003/013221 patent/WO2003093281A1/en active IP Right Grant
- 2003-04-29 CN CN038154684A patent/CN1665823A/zh active Pending
-
2004
- 2004-10-28 IL IL16490404A patent/IL164904A0/xx unknown
- 2004-11-04 ZA ZA200408934A patent/ZA200408934B/xx unknown
- 2004-11-16 HR HR20041070A patent/HRP20041070A2/hr not_active Application Discontinuation
- 2004-11-26 NO NO20045192A patent/NO20045192L/no not_active Application Discontinuation
-
2006
- 2006-07-07 US US11/482,486 patent/US20060252942A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200408934B (en) | 2006-07-26 |
MXPA04010846A (es) | 2005-01-25 |
CN1665823A (zh) | 2005-09-07 |
NO20045192L (no) | 2005-01-28 |
ATE364611T1 (de) | 2007-07-15 |
WO2003093281A1 (en) | 2003-11-13 |
KR20040104654A (ko) | 2004-12-10 |
EP1499623B1 (de) | 2007-06-13 |
EP1499623A1 (de) | 2005-01-26 |
IL164904A0 (en) | 2005-12-18 |
US20050020655A1 (en) | 2005-01-27 |
HRP20041070A2 (en) | 2005-02-28 |
CA2483566A1 (en) | 2003-11-13 |
AU2003223764A1 (en) | 2003-11-17 |
PT1499623E (pt) | 2007-08-10 |
DE60314400D1 (de) | 2007-07-26 |
US20060252942A1 (en) | 2006-11-09 |
DE60314400T2 (de) | 2008-02-07 |
ES2288606T3 (es) | 2008-01-16 |
PL373191A1 (en) | 2005-08-22 |
JP2005529142A (ja) | 2005-09-29 |
US7098345B2 (en) | 2006-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200626580A (en) | Synthesis of (5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester | |
NO20063132L (no) | Naftyridinderivater og deres anvendelse som modulatorer av muskarinreceptorer | |
NO20071629L (no) | Fremgangsmate for fremstilling av 2,7-oktadienylderivater | |
AU2003202585A1 (en) | Disubstituted thiazolyl carboxanilides and their use as microbicides | |
NO20060417L (no) | Fremgangsmate til fremstilling av 1-okten fra krakk-C4 | |
MXPA05013652A (es) | Modulador del receptor canabinoide. | |
DK1499623T3 (da) | Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on | |
Verrier et al. | Highly diastereoselective addition of alkoxyethynyl aluminium reagents to N-tert-butylsulfinyl aldimines | |
WO2021076835A8 (en) | Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid | |
WO2008021491A3 (en) | Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones | |
WO2004111047A3 (en) | Cycloalkanepyrrolopyridines as dp receptor antagonists | |
MX2022006142A (es) | Proceso para la sintesis de (3-cloro-2-piridil)hidrazina. | |
DK0595111T3 (da) | Carbazolonderivater og fremgangsmåde til deres fremstilling | |
IL185329A0 (en) | Conversion of 2-pyrazolines to pyrazoles using bromine | |
DK1102765T3 (da) | Fremgangsmåde til syntese af (1H)-benzo[c]quinolizin-3-on-derivater | |
HK1094575A1 (en) | A process for the preparation of phenyltetrazole derivatives | |
RS20050933A (en) | Process for the preparation of nonpeptide substit uted spirobenzoazepine derivatives | |
TW200626555A (en) | A process for the preparation of 1, 3, 5-trisubstituted pyrazoles via [3+2] cycloaddition | |
MX2009009232A (es) | Nuevo procedimiento de preparacion de 3-metil-4-fenilsoxazolo [3,4-d]piridazin-7(6h)-ona. | |
DK1389188T3 (da) | Fremgangsmåde til fremstilling af biperiden II | |
WO2005047215A3 (en) | Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto | |
RS20110079A (en) | MICROBIOLOGICAL PROCEDURE FOR THE PREPARATION OF 7ALFA-SUBSTITUTED 11ALFA-HYDROXYSTEROIDS | |
UA86082C2 (ru) | Производные 4-арилморфолин-3-она, способ их получения и их применение в терапии | |
MX2021007505A (es) | Síntesis de 3-metil-1,2,4-tiadiazol-5-carbohidrazida o de su forma deuterada con metil-d3. | |
MX2023002890A (es) | Procesos e intermedios para la preparacion de (s)-5-amino-3-(4-((5-fluoro-2-metoxibenzamido)metil)fenil)-1-(1,1 ,1-trifluoropropan-2-il)-1h-pirazol-4-carboxamida. |